Programme
Endoscopy Live Demonstration from Prince of Wales Hospital, Hong Kong (1)
Endoscopy Live Demonstration (1) from Prince of Wales Hospital, Hong Kong
State Key Lab Meeting (1): Microbiome and Cancer
Using genetics to explore microbe-host interactions at the molecular level
Gut microbiome dynamics in MASLD: Implications for liver cancer
GUT-IDDF Young Investigator Award: Oral Presentation I
Room N102 & 3
09:00-10:30
GUT-IDDF Young Investigator Award: Oral Presentation I
Opening of the Conference
Room N111 & 12
09:00-09:20
Opening of the Conference
Greater China Meeting (1)
Room N111 & 12
09:20-10:30
Chair |
: |
Yu-lan LIU, Deng-Chyang WU and Yun-wong LAU |
Portal hypertensive enteropathy - Translational medicine research
Intestinal microecology and colorectal cancer
Room N102 & 3
10:30-11:00
Greater China Meeting (2)
Room N111 & 12
10:30-11:40
Chair |
: |
Guo-qiang XU, Cheng-tang CHIU, Wei-guo DONG |
Biliary pancreatic diseases
Flexible robotics for endoluminal surgery - Current and future development
Application of surgical drainage concept in the endoscopic minimally invasive treatment
Endoscopy Live Demonstration from Prince of Wales Hospital, Hong Kong (2)
Endoscopy Live Demonstration (2) from Prince of Wales Hospital, Hong Kong
State Key Lab Meeting (2): Microbiome/Metabolites, Gut-liver Axis and Liver Diseases
GUT-IDDF Young Investigator Award: Oral Presentation II
Room N102 & 3
11:00-12:30
GUT-IDDF Young Investigator Award: Oral Presentation II
Greater China Meeting (3)
Room N111 & 12
11:40-12:50
Chair |
: |
Gui-qi WANG, Bin HU and Guo-xin ZHANG |
Interventional EUS, our experiences
Beyond image-based endoscopy AI: What’s next?
Room N111 & 12
12:50-14:00
Room N111 & 12
14:00-15:30
Dr S H Ho Memorial Lecture
The Obesity-GERD connection
Joseph Sung Distinguished Lecture
Morphogens, metabolism and MASLD
Greater China Meeting (4)
Room N111 & 12
15:30-16:40
Chair |
: |
Xiao-wei LIU, Mei LIU and Song HE |
Gastrointestinal endoscopy
Artificial intelligence gastrointestinal endoscopy
IBD Session (1): Advancements in IBD Management
IBD Session (1): Advancements in IBD Management
Hepatology Session (1): Viral Hepatitis
From hepatic steatosis to cancer: The role of metabolism in chronic hepatitis B
Long-term safety of oral nucleos(t)ide analogues
The road to 2030: Can Asia achieve viral hepatitis elimination?
Room N102 & 3
15:50-18:20
Greater China Meeting (5)
Room N111 & 12
16:40-18:10
Chair |
: |
Fei DAI, Ping CHEN and Hongzhi XU |
Intestinal microecology and gastrointestinal tumors
IBD Session (2): Cutting-Edge Issues in IBD: Advances in Imaging and Microbiome Insights
Advancements in perianal crohn's disease management: The role of ultrasound in disease monitoring and treatment efficacy
Role of gut microbiome in diagnosis and disease characterisation in IBD
Hepatology Session (2): Metabolic Dysfunction-associated Steatotic Liver Disease
Insights from recent omics studies on MASLD pathogenesis and management
Are incretin therapies the definitive solution for MASH?
** Programme last updated in April 2025